90,000
Participants
Start Date
April 30, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Dihydroartemisinin-piperaquine
Dihydroartemisinin-piperaquine is an antimalarial in the artemisinin-based combination therapy class of drugs. It is the Kenya Ministry of Health second-line treatment for malaria in Kenya.
Centers for Disease Control and Prevention
FED
Simon Kariuki
OTHER